Jarrow Formulas, Inc. and James Gormley of Citizens for Health organized a tactical meeting during Expo East, with the hopes of encouraging industry members to take a stronger stand against the recently proposed guidance on new dietary ingredients (NDIs), and to consider formation of a new trade association. In attendance were some of the industry’s largest and most influential supplement makers, retailers, and raw materials suppliers, as well as interested observers such as the founder of the American Botanical Council.
The natural products industry has been dissecting the proposed guidelines for new dietary ingredients (NDIs) since the U.S. Food and Drug Administration (FDA) made them public in July. Last month, WholeFoods explained some of the technical parts of the document and what they could mean for supplement makers. But, there’s another side of the story: the human side, specifically how companies are reacting to the document.
Gainesville, FL—Published research analyzed by the University of Florida suggests that resveratrol, a polyphenol found in grapes and other fruits, may support healthy aging. A review article published online in Molecular Nutrition and Food Research investigated thousands of laboratory tests with enzymes, animals and cultured cells to probe the effects that resveratrol has on humans.
East Rutherford, NJ—A paper published in the Journal of Medicinal Foods provides evidence that Maitake D-Fraction, a proprietary extract of the Maitake mushroom developed by Mushroom Wisdom, Inc., induces apoptosis in human breast cancer cells.
U.S. Senator Dick Durbin (D-IL) believes consumers need better information about supplements, and wants to have legislation enacted to make it so. The Dietary Supplement Labeling Act, he feels, will do the job.
Eden Prairie, MN—The U.S. Food and Drug Administration (FDA) has seized several UAS Laboratories’ probiotic products because the agency believes they are being marketed as drugs. This action follows a facility inspection from earlier this year when FDA found the company was making disease claims despite several warnings.